166 related articles for article (PubMed ID: 15516942)
21. Hematopoietic growth factor after autologous peripheral blood transplantation: comparison of G-CSF and GM-CSF.
Jansen J; Thompson EM; Hanks S; Greenspan AR; Thompson JM; Dugan MJ; Akard LP
Bone Marrow Transplant; 1999 Jun; 23(12):1251-6. PubMed ID: 10414911
[TBL] [Abstract][Full Text] [Related]
22. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
[TBL] [Abstract][Full Text] [Related]
23. Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.
Valteau-Couanet D; Faucher C; Aupérin A; Michon J; Milpied N; Boiron JM; Bourhis JH; Gisselbrecht C; Vernant JP; Pinna A; Bendahmane B; Delabarre F; Benhamou E
Bone Marrow Transplant; 2005 Sep; 36(6):547-52. PubMed ID: 16007101
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
26. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
27. A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting.
Lowenthal RM; Ragg SJ; Anderson J; Nicholson L; Harrup RA; Tuck D
Cytotherapy; 2007; 9(2):158-64. PubMed ID: 17453967
[TBL] [Abstract][Full Text] [Related]
28. G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 micrograms/kg/day.
Bolwell B; Goormastic M; Dannley R; Andresen S; Overmoyer B; Mendez Z; Kalaycioglu M; DeMars D; Wise K; Pohlman B
Bone Marrow Transplant; 1997 Feb; 19(3):215-9. PubMed ID: 9028548
[TBL] [Abstract][Full Text] [Related]
29. Late G-CSF after allogeneic bone marrow or peripheral blood stem cell transplantation: a prospective controlled trial.
Himmelmann B; Himmelmann A; Furrer K; Halter J; Schanz U
Bone Marrow Transplant; 2002 Oct; 30(8):491-6. PubMed ID: 12379887
[TBL] [Abstract][Full Text] [Related]
30. Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial.
Faber E; Pytlík R; Slabý J; Zapletalová J; Kozák T; Raida L; Papajík T; Zikesová E; Maresová I; Hamouzová M; Indrák K; Trnený M
Eur J Haematol; 2006 Dec; 77(6):493-500. PubMed ID: 17042769
[TBL] [Abstract][Full Text] [Related]
31. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
32. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
Han XH; Shi YK; He XH; Yang JL; Liu P
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
[TBL] [Abstract][Full Text] [Related]
33. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
Bolwell BJ; Goormastic M; Andresen S; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1997 Sep; 20(6):459-63. PubMed ID: 9313878
[TBL] [Abstract][Full Text] [Related]
34. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
35. A randomized study of multi-day infusion of autologous peripheral blood progenitor cells.
Abdel-Razeq H; Pohlman B; Andresen S; Kalaycio M; Overmoyer B; Wise K; Dannley R; DeMars D; Goormastic M; Bolwell B
Bone Marrow Transplant; 1998 Feb; 21(3):221-3. PubMed ID: 9489643
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in children.
Saarinen UM; Hovi L; Juvonen E; Riikonen P; Möttönen M; Mäkipernaa A
Med Pediatr Oncol; 1996 Jun; 26(6):380-6. PubMed ID: 8614373
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
38. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
39. Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial.
Dallorso S; Rondelli R; Messina C; Pession A; Giorgiani G; Fagioli F; Locatelli F; Manzitti C; Balduzzi A; Prete A; Cesaro S; Lanino E; Dini G
Haematologica; 2002 Dec; 87(12):1274-80. PubMed ID: 12495901
[TBL] [Abstract][Full Text] [Related]
40. Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantation.
Stinson TJ; Adams JR; Bishop MR; Kruse S; Tarantolo S; Bennet CL
Bone Marrow Transplant; 2000 Sep; 26(6):663-6. PubMed ID: 11041569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
